Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
Crossref DOI link: https://doi.org/10.1038/leu.2017.218
Published Online: 2017-07-28
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cheadle, E J
Lipowska-Bhalla, G
Dovedi, S J
Fagnano, E
Klein, C
Honeychurch, J
Illidge, T M
Text and Data Mining valid from 2017-07-28
Version of Record valid from 2017-07-28
Article History
First Online: 28 July 2017
Free to read: This content has been made available to all.